Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium
Author(s) -
RutgerJan Swijnenburg,
Masashi Tanaka,
Hannes Vogel,
Jeanette Baker,
Theo Kofidis,
Feny Gunawan,
Darren R. Lebl,
Anthony Caffarelli,
Jorg L. de Bruin,
Eugenia V. Fedoseyeva,
Robert C. Robbins
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.525824
Subject(s) - medicine , transplantation , immunogenicity , h&e stain , stem cell , embryonic stem cell , pathology , andrology , immune system , immunohistochemistry , immunology , biology , microbiology and biotechnology , gene , biochemistry
We investigated whether differentiation of embryonic stem cells (ESCs) in ischemic myocardium enhances their immunogenicity, thereby increasing their chance for rejection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom